Problems paying for prescription drugs Source: Montero, et al KFF, November 14, 2025 Implications for employers: Plan member interest in GLP-1 medications to treat obesity and cardiometabolic disease is likely to continue to increase
The CP treatment was 2.5 g plus 120 mg of hyaluronic acid and vitamins and minerals (open-label, three tablets per day) administered for 3 months, where skin parameters were recorded at baseline, 1, 2, and 3 months in 116 women 4560 years of age
Using much smaller amounts than clinical doses to test personal tolerance and reduce side effects
Improving Cognitive Function with Nutritional Supplements in Aging: A Comprehensive Narrative Review of Clinical Studies Investigating the Effects of Vitamins, Minerals, Antioxidants, and Other Dietary Supplements